(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting

BACKGROUND: Ovarian cancer is a serious threat for women health and the early diagnosis of this cancer might improves the survival rate of patients. The use of the targeted radiopharmaceuticals could be a non-invasive and logical method for tumor imaging. The aim of this study was to radiolabel GE11...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmanian, Najmeh, Hosseinimehr, Seyed Jalal, Khalaj, Ali, Noaparast, Zohreh, Abedi, Seyed Mohammad, Sabzevari, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414288/
https://www.ncbi.nlm.nih.gov/pubmed/28464952
http://dx.doi.org/10.1186/s40199-017-0179-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414288/
https://www.ncbi.nlm.nih.gov/pubmed/28464952
http://dx.doi.org/10.1186/s40199-017-0179-8

Ejemplares similares